Literature DB >> 20207192

Human Vaccinia virus and Pseudocowpox virus co-infection: clinical description and phylogenetic characterization.

Jônatas S Abrahão1, André T Silva-Fernandes, Felipe L Assis, Maria I Guedes, Betânia P Drumond, Juliana A Leite, Luiz F L Coelho, Filippo Turrini, Flávio G Fonseca, Zélia I P Lobato, Marieta Madureira, Paulo C Ferreira, Cláudio A Bonjardim, Giliane S Trindade, Erna G Kroon.   

Abstract

BACKGROUND: Occupational exanthematic diseases represent an important cause of public health impact and economical losses. Among the viral exanthematic diseases, two caused by poxviruses are noteworthy: the bovine vaccinia (BV), caused by the Vaccinia virus (VACV); and the milker's nodule, in which the agent is the Pseudocowpox virus (PCPV). Both agents are zoonotic and have been associated with several cases of bovine infection. In Brazilian rural areas BV has been highly prevalent, particularly in milk herds. Farmers, milkers and their close contacts developed lesions on the hands, forearms, legs and face accompanied by several systemic symptoms. Although VACV and PCPV present with similar epidemiological and transmission patterns, no VACV and PCPV co-infection cases have to date been described.
OBJECTIVES: To describe the first case of zoonotic VACV and PCVP co-infection, based on serological and molecular methods. STUDY DESIGN AND
RESULTS: In this work we report a case of a Brazilian rural worker who presented with a large severely ulcerated-pustule skin lesion, associated with fever, headache, malaise, myalgia and axillary, inguinal and cervical limphadenopathy. The worker declared occupational contact with cattle that had notable injuries on their teats. Human and bovine clinical samples were collected and submitted to serological and molecular tests. PCR and phylogenetic analysis revealed the presence of VACV DNA and PCPV DNA in the patient's lesion. Serological tests indicated anti-VACV neutralizing antibodies and molecular assays showed the presence of VACV and PCPV DNA in the patient sera. VACV and PCPV also were detected in dairy cattle.
CONCLUSION: Together, these results indicate a case of zoonotic VACV/PCPV co-infection. Epidemiological surveillance and appropriate medical treatment are essential for the control of both diseases, especially in the most severe cases, as described in the present study. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20207192     DOI: 10.1016/j.jcv.2010.02.001

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  13 in total

1.  Parapoxvirus Interleukin-10 Homologues Vary in Their Receptor Binding, Anti-Inflammatory, and Stimulatory Activities.

Authors:  Amreen Naqash; Gabriella Stuart; Roslyn Kemp; Lyn Wise
Journal:  Pathogens       Date:  2022-04-24

2.  qPCR assay for the detection of pseudocowpox virus.

Authors:  Gabriel Augusto de Oliveira Lopes; Luciana Rabello Ferreira; Giliane de Souza Trindade; Antônio Augusto Fonseca; Jenner Karlisson Pimenta Dos Reis
Journal:  Arch Virol       Date:  2020-11-07       Impact factor: 2.574

3.  Evaluating anti-Orthopoxvirus antibodies in individuals from Brazilian rural areas prior to the bovine vaccinia era.

Authors:  Poliana de Oliveira Figueiredo; André Tavares da Silva-Fernandes; Bruno Eduardo Fernandes Mota; Galileu Barbosa Costa; Iara Apolinário Borges; Paulo César Peregrino Ferreira; Jônatas Santos Abrahão; Erika Martins Braga; Erna Geessien Kroon; Giliane de Souza Trindade
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-09       Impact factor: 2.743

4.  An Investigation of a Cluster of Parapoxvirus Cases in Missouri, Feb-May 2006: Epidemiologic, Clinical and Molecular Aspects.

Authors:  Edith R Lederman; Min Tao; Mary G Reynolds; Yu Li; Hui Zhao; Scott K Smith; Lisa Sitler; Dana L Haberling; Whitni Davidson; Christina Hutson; Ginny Emerson; David Schnurr; Russell Regnery; Bao-Ping Zhu; Howard Pue; Inger K Damon
Journal:  Animals (Basel)       Date:  2013-02-28       Impact factor: 2.752

Review 5.  Vaccinia Virus Natural Infections in Brazil: The Good, the Bad, and the Ugly.

Authors:  Jaqueline Silva de Oliveira; Poliana de Oliveira Figueiredo; Galileu Barbosa Costa; Felipe Lopes de Assis; Betânia Paiva Drumond; Flávio Guimarães da Fonseca; Maurício Lacerda Nogueira; Erna Geessien Kroon; Giliane de Souza Trindade
Journal:  Viruses       Date:  2017-11-15       Impact factor: 5.048

6.  A novel HRM assay for the simultaneous detection and differentiation of eight poxviruses of medical and veterinary importance.

Authors:  Esayas Gelaye; Lukas Mach; Jolanta Kolodziejek; Reingard Grabherr; Angelika Loitsch; Jenna E Achenbach; Norbert Nowotny; Adama Diallo; Charles Euloge Lamien
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

7.  Human Infection with Orf Virus and Description of Its Whole Genome, France, 2017.

Authors:  Julien Andreani; Jessica Fongue; Jacques Y Bou Khalil; Laurene David; Saïd Mougari; Marion Le Bideau; Jonatas Abrahão; Philippe Berbis; Bernard La Scola
Journal:  Emerg Infect Dis       Date:  2019-12       Impact factor: 6.883

8.  Vaccinia Virus in Blood Samples of Humans, Domestic and Wild Mammals in Brazil.

Authors:  Marina G Peres; Thais S Bacchiega; Camila M Appolinário; Acácia F Vicente; Mateus de Souza Ribeiro Mioni; Bruna L D Ribeiro; Clóvis R S Fonseca; Vanessa C Pelícia; Fernando Ferreira; Graziele P Oliveira; Jonatas S Abrahão; Jane Megid
Journal:  Viruses       Date:  2018-01-18       Impact factor: 5.048

9.  Dairy production practices and associated risks for bovine vaccinia exposure in cattle, Brazil.

Authors:  I A Borges; A M McCollum; J M Mehal; D Haberling; L A L Dutra; F N Vieira; L A O Andrade; E G Kroon; R C Holman; M G Reynolds; G S Trindade
Journal:  New Microbes New Infect       Date:  2017-08-16

Review 10.  Poxvirus Host Range Genes and Virus-Host Spectrum: A Critical Review.

Authors:  Graziele Pereira Oliveira; Rodrigo Araújo Lima Rodrigues; Maurício Teixeira Lima; Betânia Paiva Drumond; Jônatas Santos Abrahão
Journal:  Viruses       Date:  2017-11-07       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.